ARA opposes ‘a-flagging’ of etanercept biosimilar

The ARA has raised concerns over the potential “a flagging” of etanercept biosimilar Brenzys on the PBS due to a lack of data on the safety of switching.

Brenzys has been approved by the TGA but its manufacturer Merck has submitted an application for its listing on the PBS, with the possibility it could be “a-flagged”.

This means that pharmacists would be able to substitute the prescribed